Organ on Chip Market Size, Share, Growth Analysis, By Organ Type(Liver, Kidney, Lungs, Heart), By Application(Drug-discovery, Disease Modelling, and Toxicity Testing), By End-User(Biotech &Pharma Companies, Contract Research Organisations and Academic & Research Institutes.), By Region - Industry Forecast 2024-2031

Global Organ on Chip Market size was valued at USD 52.53 Billion in 2022 and is poised to grow from USD 68.63 Billion in 2023 to USD 448.92 Billion by 2031, growing at a CAGR of 30.76% during the forecast period (2024-2031).

An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in different organs like lungs, gut, liver, heart, and others. These devices offer a wide range of applications like disease modelling, drug designing and toxicity testing. The global organ on chip market can be describe by rapid technological advancements, growing adoption across pharma, biotech and academic sectors as well as increasing fundings and investments in research and developments. For instance, in December 2021, Emulate, Inc., stated that its Brain Chip was sent to the ISS National Lab to study the effects of microgravity on human brain physiology as part of the tissue-chips in space initiative sponsored by the NCATS at NIH and the ISS-NL.

The market is majorly driven by factors such as need for alternatives for animal testing and the need for early detection of drug reactions and toxicity. According to data released by People for the Ethical Treatment of Animals, 3.52 million procedures were performed on animals in the UK in 2018. (PETA). In addition, a 2017 report by the US Department of Agriculture estimated that approximately 792,168 animals were held for experiments or used in them nationwide. In 2018, more than 3.9 million animals in Canada were subjected to research.

Moreover, the organ-on-chip technology is not limited to liver, lungs, kidney, heart etc. Stakeholders in this market are trying thier best and focusing on expanding the organ’s applications and sites with this technology. These gadgets are becoming more and more prevalent in healthcare sectors like in hospitals, clinics and research facilities' which can help in generating detailed research and treatments. The future of drug design will be majorly dependent on this technology due to its widespread use in many industries. And as the result, the adoption of organ-on-chip is expected to grow over the time.

Organ-on-chip companies are launching new products to cater to the needs of the research community. After the Covid-19 pandemic, the demand for the advancements in these technologies have witnessed a huge growth, the government as well as various health organisations are trying to focus on this subject. Based on all these driving factors, the global organ-on-chip market is anticipated to grow at a CAGR of 30.76% during the forecast period.